ARK Investment Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122M | Buy |
|
|||||
|
2025
Q1 | $92.5M | Buy |
|
|||||
|
2024
Q4 | $146M | Buy |
|
|||||
|
2024
Q3 | $252M | Buy |
|
|||||
|
2024
Q2 | $260M | Buy |
|
|||||
|
2024
Q1 | $302M | Sell |
|
|||||
|
2023
Q4 | $348M | Buy |
|
|||||
|
2023
Q3 | $315M | Buy |
|
|||||
|
2023
Q2 | $388M | Sell |
|
|||||
|
2023
Q1 | $367M | Buy |
|
|||||
|
2022
Q4 | $329M | Sell |
|
|||||
|
2022
Q3 | $540M | Buy |
|
|||||
|
2022
Q2 | $439M | Buy |
|
|||||
|
2022
Q1 | $653M | Buy |
|
|||||
|
2021
Q4 | $936M | Buy |
|
|||||
|
2021
Q3 | $905M | Sell |
|
|||||
|
2021
Q2 | $1.24B | Sell |
|
|||||
|
2021
Q1 | $771M | Sell |
|
|||||
|
2020
Q4 | $609M | Sell |
|
|||||
|
2020
Q3 | $227M | Buy |
|
|||||
|
2020
Q2 | $240M | Buy |
|
|||||
|
2020
Q1 | $125M | Buy |
|
|||||
|
2019
Q4 | $128M | Buy |
|
|||||
|
2019
Q3 | $113M | Buy |
|
|||||
|
2019
Q2 | $135M | Buy |
|
|||||
|
2019
Q1 | $136M | Buy |
|
|||||
|
2018
Q4 | $92.8M | Buy |
|
|||||
|
2018
Q3 | $165M | Buy |
|
|||||
|
2018
Q2 | $123M | Buy |
|
|||||
|
2018
Q1 | $76M | Buy |
|
|||||
|
2017
Q4 | $26.4M | Buy |
|
|||||
|
2017
Q3 | $9.26M | Buy |
|
|||||
|
2017
Q2 | $2.8M | Buy |
|
|||||
|
2017
Q1 | $1.13M | Buy |
|
|||||
|
2016
Q4 | $348K | Buy |
|